Three Stocks, Three Stories. A plain-English breakdown of what's driving CLS, PLTR, and ATZ — and whether the moment to act has passed.
Charts don't lie — but they do require translation. What looks like three unrelated stocks moving in three different directions is actually one coherent story about a single idea: is the stock cheap or expensive relative to what the business is actually worth right now?
The three stocks at a glance
▲ Healthy consolidation
BusinessBuilds AI servers & hardware
Price (Apr 7)US$297
From peak−17% below ATH
Revenue growth+28% in 2025 · +37% guided 2026
Valuation feelReasonable — ~34× fwd earnings
Chart trendStill above 200-day average ✓
▼ Triple top breakdown
BusinessAI analytics software
Price (Apr 10)US$128
From peak−38% below ATH of $208
Revenue growth+56% in 2025 · strong business
Valuation feelVery stretched — ~100× fwd earnings
Chart trendFighting to hold key support levels
▲ Triple bottom breakout
BusinessWomen's fashion retail (Canada/US)
Price (Apr 9)C$127
From ATHOnly −9% from Jan 2026 peak
Revenue growth+43% Q3 FY26 · US revenue +54%
Valuation feelRecovering from cheap — earnings exploding
Chart trendFresh breakout from a long base ✓
"A great business and a great stock are two different things. What separates them is the price you're paying relative to what that business is actually earning today."
Part 1 — Why the charts went in opposite directions
The most important thing to understand is that stock charts don't generate their own direction — they are a consequence of the relationship between what the business is worth and what people are paying for it. All three patterns below are logical outcomes of that relationship.
Palantir · Triple top + descending breakdown
The price ran years ahead of the earnings
Palantir's business is genuinely excellent — revenue grew 56% in 2025, they are profitable, and their AI software is used by the US military and major corporations. The problem is not the business. The problem is the price investors were willing to pay for it.
At its peak ($208 in November 2025), Palantir was trading at over 200 times its annual earnings. That means investors were paying $200 for every $1 of profit the company made per year. For context, the average stock in the S&P 500 trades at about 20–25 times earnings. Palantir was priced at roughly 8–10x that level.
A triple top forms when the stock tries three times to push through a price ceiling — and fails each time. Why does it fail? Because rational, experienced investors look at a $200 price with 200× earnings and say: "even if this company grows perfectly for the next decade, I'm not buying at this price." Those sellers overwhelm the buyers at that level, three times in a row.
The descending triangle breakdown that follows is what happens next: each rally is weaker than the last, lower and lower highs, while a floor temporarily holds — until even the floor breaks. This is not the company falling apart. This is the price falling back toward something more justifiable. The business is still growing at 60%+.
Aritzia · Triple bottom + upside breakout
The price was punished far below what the business was worth
Aritzia went through a difficult 2023–2024. They over-ordered inventory during supply chain chaos, warehousing costs exploded, profit margins got squeezed. The stock collapsed from prior highs all the way to C$38 — a drop of well over 60%. The market was pricing in "this brand is broken."
But the brand wasn't broken. The problems were temporary operational headaches, not structural failures. The stores kept doing well. US customers kept discovering Aritzia. The underlying loyal customer base was intact.
A triple bottom forms when the stock falls to the same low price three separate times — and each time, it bounces. Why does it bounce? Because value investors, who had done their homework, saw a business earning real money being sold at a deep discount, and they kept buying. Three times, the sellers couldn't push it lower.
The upside breakout in March 2026 happened because the numbers finally proved the bears wrong, quarter after quarter. Revenue grew 33%, then 32%, then 43%. US revenue surged 54% in a single quarter. Profit margins bounced back strongly. When the fundamentals recover faster than the stock does, the stock eventually catches up — sometimes very quickly.
Celestica · Healthy bull consolidation
The price was late to catch up to a business that had quietly transformed
Celestica spent years being treated by the market as a boring, low-margin electronics manufacturer. Then the AI data centre boom happened, and it turned out that the servers, switches, and networking hardware that all this AI runs on — Celestica was one of the companies building them. Revenue went from $9.7B in 2024 to $12.4B in 2025, with $17B guided for 2026.
The stock spent much of 2022–2023 in the $20–40 range. It then re-rated dramatically as investors woke up to what Celestica actually was. The chart looks similar to Aritzia's recovery — a base period followed by a sharp re-rating when earnings confirmed the thesis.
The current pullback from ATH ($363 → ~$297) is a normal digestion period after a very large move. The stock remains well above its 200-day moving average and the underlying business is still guided to grow 37% next year. This is consolidation, not collapse.
Part 2 — The key factors behind each chart pattern
| Contributing factor |
Plain English |
CLS |
PLTR |
ATZ |
| Starting valuation |
Was the stock cheap or expensive relative to earnings when the pattern began? |
Cheap — priced as a legacy manufacturer |
Extremely expensive — 200× earnings |
Cheap — priced as a broken business |
| Earnings momentum |
Was the business getting better or worse as the chart formed? |
Strongly accelerating — AI hardware demand exploded |
Also accelerating — but irrelevant at 200× PE |
Recovering sharply — margins and revenue surging back |
| Business model |
Does the company make physical things, or sell software licenses? |
Physical manufacturing — capital-intensive, real assets |
Pure software — nearly infinite scalability, high margins |
Physical retail + eCommerce — capital-intensive, real stores |
| Multiple regime |
How much is the market willing to pay per dollar of earnings? |
34× forward — growth stock premium, but grounded |
100–200× — narrative/story premium, fragile |
Moderate — re-rating higher as earnings compound |
| Sentiment risk |
How vulnerable is the stock to changes in mood or narrative? |
Moderate — customer concentration risk, tariff noise |
Very high — any AI competitor news triggers selloff |
Moderate — tariff fears, consumer spending slowdown risk |
| Pattern resolution driver |
What actually caused the chart to break up or down? |
Earnings beats quarter after quarter confirmed the AI hardware thesis |
Valuation gravity — price too far from earnings reality |
Margin recovery + US revenue explosion proved the critics wrong |
| Where it sits today |
Is the stock above or below key technical trend indicators? |
Above 200-day moving average — uptrend intact |
Fighting to reclaim the 200-day — trend uncertain |
Fresh breakout — strongest technical posture of the three |
Part 3 — Is it too late to add CLS or introduce ATZ?
The real question to ask
"Cheap" is not about whether the stock went up. It's about whether today's price is low relative to what the business will earn.
This is the most important reframe. A stock that has risen 200% can still be cheap if its earnings are growing fast enough. A stock that has fallen 40% can still be expensive if it was priced for absolute perfection. The question is not "did I miss the move?" — it's "is the current price a good deal relative to the earnings power of this business today and over the next 2–3 years?"
Celestica (CLS) — adding more
✓
The business is still accelerating. Revenue guided to $17B in 2026 (+37%). New hyperscaler win for 1.6T switching platform. AMD Helios AI rack partnership announced March 2026.
✓
The valuation is not stretched. At ~34× forward earnings, CLS is priced as a growth company but not as a miracle. If $17B revenue is delivered and margins hold at ~7.5%, that is fully supportable at current prices.
✓
The chart pullback is healthy, not broken. −17% from ATH with stock above 200-day MA is a normal breather after a large move, not a trend reversal. The 52-week low was $58 — it is not "too high" in historical context.
⚠
The risk to watch: Three customers = 63% of revenue. If the largest hyperscaler cuts orders, the stock reacts sharply. Q1 2026 earnings on April 27 is the first update — pay close attention to tariff guidance revision and demand commentary.
→
Verdict: Not "chasing high." The stock is consolidating within a continuing growth story. Adding on dips toward the $270–280 range (closer to 200-day MA) improves entry risk. Not urgent to buy ahead of April 27 earnings.
Aritzia (ATZ) — introducing a position
✓
The breakout is fresh. The triple bottom resolved upward only in March 2026 — buyers issued from a pivot bottom and the stock has risen ~19% since. Early in the new uptrend, not late.
✓
The earnings trajectory is compelling. US revenue +54% in Q3 FY26. Net income up 87%. EBITDA margins expanding toward 19–20% target despite tariff headwinds. The recovery is broad-based and accelerating.
✓
Long US expansion runway. 66 US boutiques today, targeting 200+. New stores have 12–18 month payback on a $4M investment generating $10M revenue. The growth engine has many years of runway.
⚠
Risks are real: Tariffs create ~280 basis points of gross margin pressure. US consumer spending could slow in a recession. The stock is a TSX-listed CAD stock — currency impact on USD-based investors matters.
→
Verdict: The fresh breakout from a multi-year base is technically the strongest posture of the three stocks. Not a "chase" — this is a first-inning entry into a recovery story that still has significant room. Q4 FY26 earnings on April 30 is the near-term catalyst to watch.
Valuation at a glance — how "cheap" is each stock today?
Forward P/E ratio — how many dollars you pay per $1 of annual profit (lower = cheaper)
CLS and ATZ are both priced at a premium to the average stock — because they're growing much faster than the average stock. But neither is priced at Palantir's extreme, where even exceptional growth may not justify the cost. The question is whether their growth justifies the premium — and recent earnings suggest it does.
Upcoming catalysts — earnings season is here
Apr 27
CLS
Celestica Q1 2026 results (after market). Key focus: tariff guidance update, ATS segment A&D commentary, hyperscaler demand signals for H2 2026. Conference call April 28 at 8am ET.
High impact ↑
Apr 30
ATZ
Aritzia Q4 FY2026 results. Watch for full-year FY2027 guidance — this will set the stage for whether the US expansion trajectory continues at 50%+ or begins to moderate.
High impact ↑
May 11
PLTR
Palantir Q1 2026. If US commercial growth shows any deceleration from 120%+ to even "only" 80%, the multiple compresses rapidly. A beat could trigger a significant bounce — the stock is down 38% from ATH and short interest is elevated.
Volatile either way
Buying "high" is only chasing if the price has run past the fundamentals. Buying a stock that's gone up but whose earnings have gone up more is not chasing — it's recognising value that took time to become obvious.
A note on this document
This is a personal research summary reflecting the author's analysis of publicly available financial data as of April 2026. It is not professional investment advice, and all investment decisions carry risk of loss. Past earnings growth does not guarantee future results. Always do your own research before making any investment decisions.
For informational purposes only. Not financial advice. Data approximate as of April 9–11, 2026. Past performance does not guarantee future results. Consult a qualified financial advisor before making investment decisions.
PERSONAL RESEARCH · 2026 · CLS · PLTR · ATZ